WHO Model List of Essential Medicines
The WHO Model List of Essential Medicines which serves as a guide for the development of national and institutional essential medicine lists is updated and revised every two years by the WHO Expert Committee on Selection and Use of Medicines. The 18th WHO Model List of Essential Medicines and 4th WHO Model List of Essential Medicines for Children were endorsed by the 19th WHO Expert Committee on Selection and Use which met in April 2013.
National Essential Medicines Lists
Most countries have national lists and some have provincial or state lists as well. National lists of essential medicines guide the procurement and supply of medicines in the public sector, schemes that reimburse medicine costs, medicine donations, and local medicine production.
WHO compiles country information on national Essential Medicines Lists, national medicine policy and national Standard Treatment Guidelines.
WHO Model Formulary
Since its first publication in 2002, the WHO Model Formulary has become an source of independent information on essential medicines for pharmaceutical policy-makers and prescribers worldwide. For each medicine the Formulary provides information on use, dosage, adverse effects, contraindications and warnings, supplemented by guidance on selecting the right medicine for a range of conditions.
Please send any comments, suggestions or amendments, as well as any request for the WHO Model Formulary in an editable format to email@example.com.
- Revised procedure for updating WHO's Model List of Essential Drugs. Executive Board document EB109/8, 7 December 2001
Essential Medicines List (EML) 2015 – Application form
Essential Medicines List (EML) 2015 – Commented application
Comparative Table of Medicines on the WHO Essential Medicines List from 1977- 2011
List of medicines deleted from previous EMLs
List of rejected applications
- Essential Medicines Lists
- WHO Technical Report Series (Reports of the Expert Committees)
Policy, Access and Use (PAU)
20 Avenue Appia
CH-1211 Geneva 27